LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · Real-Time Price · USD
84.53
-1.17 (-1.37%)
Dec 5, 2025, 4:00 PM EST - Market closed
LeMaitre Vascular Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for LeMaitre Vascular stock ranges from a low of $93 to a high of $110. The average analyst price target of $101.83 forecasts a 20.47% increase in the stock price over the next year.
Price Target: $101.83 (+20.47%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for LeMaitre Vascular stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 1 | 2 | 2 | 2 | 1 | 1 |
| Hold | 3 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $97 → $93 | Hold | Maintains | $97 → $93 | +10.02% | Nov 7, 2025 |
| Roth Capital | Roth Capital | Strong Buy Initiates $108 | Strong Buy | Initiates | $108 | +27.77% | Nov 5, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $95 | Buy | Maintains | $95 | +12.39% | Oct 15, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $95 | Buy | Maintains | $95 | +12.39% | Sep 23, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $92 → $95 | Hold | Maintains | $92 → $95 | +12.39% | Aug 6, 2025 |
Financial Forecast
Revenue This Year
253.22M
from 219.86M
Increased by 15.17%
Revenue Next Year
276.19M
from 253.22M
Increased by 9.07%
EPS This Year
2.48
from 1.93
Increased by 28.39%
EPS Next Year
2.64
from 2.48
Increased by 6.49%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 263.6M | 290.1M | ||||
| Avg | 253.2M | 276.2M | ||||
| Low | 242.1M | 258.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 19.9% | 14.6% | ||||
| Avg | 15.2% | 9.1% | ||||
| Low | 10.1% | 2.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.65 | 2.97 | |||
| Avg | 2.48 | 2.64 | |||
| Low | 2.25 | 2.34 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 37.1% | 19.9% | |||
| Avg | 28.4% | 6.5% | |||
| Low | 16.8% | -5.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.